Secondary endpoints were changes in lipids other than total cholesterol , insulin sensitivity , total bilirubin , estimated glomerular filtration rate , and CD@ and CD@ cell counts , and the proportion of patients with plasma HIV RNA < @ HIV-@ RNA copies/mL and study drug discontinuation because of adverse effects at @ weeks .